These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38268491)

  • 1. Biphasic effects of cannabis and cannabinoid therapy on pain severity, anxiety, and sleep disturbance: a scoping review.
    Shustorovich A; Corroon J; Wallace MS; Sexton M
    Pain Med; 2024 May; 25(6):387-399. PubMed ID: 38268491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions.
    Bell AD; MacCallum C; Margolese S; Walsh Z; Wright P; Daeninck PJ; Mandarino E; Lacasse G; Kaur Deol J; de Freitas L; St Pierre M; Belle-Isle L; Gagnon M; Bevan S; Sanchez T; Arlt S; Monahan-Ellison M; O'Hara J; Boivin M; Costiniuk C
    Cannabis Cannabinoid Res; 2024 Apr; 9(2):669-687. PubMed ID: 36971587
    [No Abstract]   [Full Text] [Related]  

  • 3. Cannabis and Cannabinoids for Chronic Pain.
    Romero-Sandoval EA; Kolano AL; Alvarado-Vázquez PA
    Curr Rheumatol Rep; 2017 Oct; 19(11):67. PubMed ID: 28983880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding Cannabis-Based Therapeutics in Sports Medicine.
    Maurer GE; Mathews NM; Schleich KT; Slayman TG; Marcussen BL
    Sports Health; 2020; 12(6):540-546. PubMed ID: 32936058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance.
    Narayan AJ; Downey LA; Manning B; Hayley AC
    Neurosci Biobehav Rev; 2022 Dec; 143():104941. PubMed ID: 36370842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies.
    Noori A; Miroshnychenko A; Shergill Y; Ashoorion V; Rehman Y; Couban RJ; Buckley DN; Thabane L; Bhandari M; Guyatt GH; Agoritsas T; Busse JW
    BMJ Open; 2021 Jul; 11(7):e047717. PubMed ID: 34321302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and correlates of sleep-related problems in adults receiving medical cannabis for chronic pain.
    Cranford JA; Arnedt JT; Conroy DA; Bohnert KM; Bourque C; Blow FC; Ilgen M
    Drug Alcohol Depend; 2017 Nov; 180():227-233. PubMed ID: 28926791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical cannabis and cannabinoids for impaired sleep: a systematic review and meta-analysis of randomized clinical trials.
    AminiLari M; Wang L; Neumark S; Adli T; Couban RJ; Giangregorio A; Carney CE; Busse JW
    Sleep; 2022 Feb; 45(2):. PubMed ID: 34546363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials.
    Wang L; Hong PJ; May C; Rehman Y; Oparin Y; Hong CJ; Hong BY; AminiLari M; Gallo L; Kaushal A; Craigie S; Couban RJ; Kum E; Shanthanna H; Price I; Upadhye S; Ware MA; Campbell F; Buchbinder R; Agoritsas T; Busse JW
    BMJ; 2021 Sep; 374():n1034. PubMed ID: 34497047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report.
    Abrams DI
    Eur J Intern Med; 2018 Mar; 49():7-11. PubMed ID: 29325791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
    Whiting PF; Wolff RF; Deshpande S; Di Nisio M; Duffy S; Hernandez AV; Keurentjes JC; Lang S; Misso K; Ryder S; Schmidlkofer S; Westwood M; Kleijnen J
    JAMA; 2015 Jun 23-30; 313(24):2456-73. PubMed ID: 26103030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis and schizophrenia.
    McLoughlin BC; Pushpa-Rajah JA; Gillies D; Rathbone J; Variend H; Kalakouti E; Kyprianou K
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004837. PubMed ID: 25314586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
    Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis for Chronic Pain: Challenges and Considerations.
    Romero-Sandoval EA; Fincham JE; Kolano AL; Sharpe BN; Alvarado-Vázquez PA
    Pharmacotherapy; 2018 Jun; 38(6):651-662. PubMed ID: 29637590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review.
    Wright P; Walsh Z; Margolese S; Sanchez T; Arlt S; Belle-Isle L; St Pierre M; Bell A; Daeninck P; Gagnon M; Lacasse G; MacCallum C; Mandarino E; Yale J; O'Hara J; Costiniuk C
    BMJ Open; 2020 May; 10(5):e036114. PubMed ID: 32448797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms.
    Gruber SA; Smith RT; Dahlgren MK; Lambros AM; Sagar KA
    Exp Clin Psychopharmacol; 2021 Apr; 29(2):147-156. PubMed ID: 33764103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical Cannabis for Older Patients.
    Minerbi A; Häuser W; Fitzcharles MA
    Drugs Aging; 2019 Jan; 36(1):39-51. PubMed ID: 30488174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
    Sarris J; Sinclair J; Karamacoska D; Davidson M; Firth J
    BMC Psychiatry; 2020 Jan; 20(1):24. PubMed ID: 31948424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.
    Black N; Stockings E; Campbell G; Tran LT; Zagic D; Hall WD; Farrell M; Degenhardt L
    Lancet Psychiatry; 2019 Dec; 6(12):995-1010. PubMed ID: 31672337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids, Insomnia, and Other Sleep Disorders.
    Lavender I; McGregor IS; Suraev A; Grunstein RR; Hoyos CM
    Chest; 2022 Aug; 162(2):452-465. PubMed ID: 35537535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.